Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers
- PMID: 22820554
- PMCID: PMC3485563
- DOI: 10.1016/j.neuropharm.2012.07.009
Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers
Abstract
Background: Modafinil, a putative cognitive enhancing drug, has previously been shown to improve performance of healthy volunteers as well as patients with attention deficit disorder and schizophrenia, mainly in tests of executive functions. The aim of this study was to investigate the effects of modafinil on non-verbal cognitive functions in healthy volunteers, with a particular focus on variations of cognitive load, measures of motivational factors and the effects on creative problem-solving.
Methods: A double-blind placebo-controlled parallel design study evaluated the effect of 200 mg of modafinil (N = 32) or placebo (N = 32) in non-sleep deprived healthy volunteers. Non-verbal tests of divergent and convergent thinking were used to measure creativity. A new measure of task motivation was used, together with more levels of difficulty on neuropsychological tests from the CANTAB battery.
Results: Improvements under modafinil were seen on spatial working memory, planning and decision making at the most difficult levels, as well as visual pattern recognition memory following delay. Subjective ratings of enjoyment of task performance were significantly greater under modafinil compared with placebo, but mood ratings overall were not affected. The effects of modafinil on creativity were inconsistent and did not reach statistical significance.
Conclusions: Modafinil reliably enhanced task enjoyment and performance on several cognitive tests of planning and working memory, but did not improve paired associates learning. The findings confirm that modafinil can enhance aspects of highly demanding cognitive performance in non-sleep deprived individuals. This article is part of a Special Issue entitled 'Cognitive Enhancers'.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial.Psychol Med. 2017 Oct;47(13):2358-2368. doi: 10.1017/S0033291717000885. Epub 2017 May 3. Psychol Med. 2017. PMID: 28464963 Clinical Trial.
-
Modafinil combined with cognitive training is associated with improved learning in healthy volunteers--a randomised controlled trial.Eur Neuropsychopharmacol. 2014 Apr;24(4):529-39. doi: 10.1016/j.euroneuro.2014.01.001. Epub 2014 Jan 16. Eur Neuropsychopharmacol. 2014. PMID: 24485800 Clinical Trial.
-
Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia.Neuropsychopharmacology. 2004 Jul;29(7):1363-73. doi: 10.1038/sj.npp.1300457. Neuropsychopharmacology. 2004. PMID: 15085092 Clinical Trial.
-
A State-of-the-Art Review on the Use of Modafinil as A Performance-enhancing Drug in the Context of Military Operationality.Mil Med. 2022 Jan 4;187(1-2):52-64. doi: 10.1093/milmed/usab398. Mil Med. 2022. PMID: 34632515 Review.
-
Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review.Eur Neuropsychopharmacol. 2015 Nov;25(11):1865-81. doi: 10.1016/j.euroneuro.2015.07.028. Epub 2015 Aug 20. Eur Neuropsychopharmacol. 2015. PMID: 26381811 Review.
Cited by
-
Behavioral and neurophysiological signatures of cognitive control in humans and rats.Int J Neuropsychopharmacol. 2024 Nov 1;27(11):pyae050. doi: 10.1093/ijnp/pyae050. Int J Neuropsychopharmacol. 2024. PMID: 39447056 Free PMC article.
-
Cognitive enhancement: Effects of methylphenidate, modafinil, and caffeine on latent memory and resting state functional connectivity in healthy adults.Hum Brain Mapp. 2022 Oct 1;43(14):4225-4238. doi: 10.1002/hbm.25949. Epub 2022 Jun 7. Hum Brain Mapp. 2022. PMID: 35670369 Free PMC article. Clinical Trial.
-
Effects of modafinil on electroencephalographic microstates in healthy adults.Psychopharmacology (Berl). 2022 Aug;239(8):2573-2584. doi: 10.1007/s00213-022-06149-x. Epub 2022 Apr 26. Psychopharmacology (Berl). 2022. PMID: 35471613 Free PMC article.
-
Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.Drugs. 2022 Apr;82(6):633-647. doi: 10.1007/s40265-022-01701-7. Epub 2022 Apr 2. Drugs. 2022. PMID: 35366192 Review.
-
A multi-pronged investigation of option generation using depression, PET and modafinil.Brain. 2022 Jun 3;145(5):1854-1865. doi: 10.1093/brain/awab429. Brain. 2022. PMID: 35150243 Free PMC article. Clinical Trial.
References
-
- Aron A.R., Dowson J.H., Sahakian B.J., Robbins T.W. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry. 2003;54:1465–1468. - PubMed
-
- Benerjee D., Vitiellob M.V., Grunsteinc R.R. Psychopharmacology for excessive daytime sleepiness. Sleep Med. Rev. 2004;8:339–354. - PubMed
-
- Blackwell A.D., Sahakian B.J., Vesey R., Semple J.M., Robbins T.W., Hodges J.R. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Demen. Geriat. Cogn. Dis. 2004;17:42–48. - PubMed
-
- Bond A., Lader M. The use of analogue scales in rating subjective feelings. Br. J. Med. Psychol. 1974;47:211–218.
-
- CANTABeclipse™ . Cambridge Cognition Limited; 2011. Test Administration Guide. Manual Version 4.0.0.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
